{"nct_id":"NCT02423343","title":"A Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in Recurrent or Refractory NSCLC, or Hepatocellular Carcinoma","status":"COMPLETED","status_verified_date":"2021-08","start_date":"2015-01-01","start_date_type":"ACTUAL","primary_completion_date":"2018-12-13","primary_completion_date_type":"ACTUAL","completion_date":"2020-07-08","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["LLY"]}